Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-011921

Chief Medical Officer acquired 10,000 shares (option exercise)

  • Chief Medical Officer acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pang Phillip · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Exercise or conversion : show line 1 in the form +10,000 $0.86 $8,550 77,277 D
2021-02-16 Grant or award : show line 2 in the form +32,000 109,277 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 33,833 D
2021-02-16 Grant or award : show line 4 in the form Stock Option (Right to Buy) +64,000 64,000 D
Loading xslF345X03/doc4.xml…